Mathieu Dube, Ph.D. - Publications

Affiliations: 
2011 Université de Montréal, Montréal, Canada 
Area:
Microbiology Biology, Virology Biology

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lemieux A, Sannier G, Nicolas A, Nayrac M, Delgado GG, Cloutier R, Brassard N, Laporte M, Duchesne M, Sreng Flores AM, Finzi A, Tastet O, Dubé M, Kaufmann DE. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay. Cell Reports Methods. 100690. PMID 38228152 DOI: 10.1016/j.crmeth.2023.100690  0.36
2023 Dubé M, Tastet O, Dufour C, Sannier G, Brassard N, Delgado GG, Pagliuzza A, Richard C, Nayrac M, Routy JP, Prat A, Estes JD, Fromentin R, Chomont N, Kaufmann DE. Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4 and CD8 T cells. Cell Host & Microbe. 31: 1507-1522.e5. PMID 37708853 DOI: 10.1016/j.chom.2023.08.006  0.457
2023 Richard J, Prévost J, Bourassa C, Brassard N, Boutin M, Benlarbi M, Goyette G, Medjahed H, Gendron-Lepage G, Gaudette F, Chen HC, Tolbert WD, Smith AB, Pazgier M, Dubé M, et al. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120. Cell Chemical Biology. PMID 36958337 DOI: 10.1016/j.chembiol.2023.03.003  0.545
2023 Sannier G, Nicolas A, Dubé M, Marchitto L, Nayrac M, Tastet O, Chatterjee D, Tauzin A, Lima-Barbosa R, Laporte M, Cloutier R, Sreng Flores AM, Boutin M, Gong SY, Benlarbi M, et al. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4 T cell profile. Cell Reports. Medicine. 100955. PMID 36863335 DOI: 10.1016/j.xcrm.2023.100955  0.385
2022 Nicolas A, Sannier G, Dubé M, Nayrac M, Tauzin A, Painter MM, Goel RR, Laporte M, Gendron-Lepage G, Medjahed H, Williams JC, Brassard N, Niessl J, Gokool L, Morrisseau C, et al. Extended SARS-CoV-2 mRNA vaccine prime-boost intervals enhances B cell immunity with limited impact on T cells. Iscience. 105904. PMID 36594081 DOI: 10.1016/j.isci.2022.105904  0.356
2022 Brunet-Ratnasingham E, Morou A, Dubé M, Niessl J, Baxter AE, Tastet O, Brassard N, Ortega-Delgado G, Charlebois R, Freeman GJ, Tremblay C, Routy JP, Kaufmann DE. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function. Ebiomedicine. 84: 104254. PMID 36150362 DOI: 10.1016/j.ebiom.2022.104254  0.44
2022 Wietgrefe SW, Duan L, Anderson J, Marqués G, Sanders M, Cummins NW, Badley AD, Dobrowolski C, Karn J, Pagliuzza A, Chomont N, Sannier G, Dubé M, Kaufmann DE, Zuck P, et al. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection. Journal of Virology. e0088522. PMID 35856674 DOI: 10.1128/jvi.00885-22  0.397
2022 Nayrac M, Dubé M, Sannier G, Nicolas A, Marchitto L, Tastet O, Tauzin A, Brassard N, Lima-Barbosa R, Beaudoin-Bussières G, Vézina D, Gong SY, Benlarbi M, Gasser R, Laumaea A, et al. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen. Cell Reports. 39: 111013. PMID 35732172 DOI: 10.1016/j.celrep.2022.111013  0.537
2022 Dubé M, Kaufmann DE. Single-Cell Multiparametric Analysis of Rare HIV-Infected Cells Identified by Duplexed RNAflow-FISH. Methods in Molecular Biology (Clifton, N.J.). 2407: 291-313. PMID 34985672 DOI: 10.1007/978-1-0716-1871-4_20  0.401
2021 Nayrac M, Dubé M, Sannier G, Nicolas A, Marchitto L, Tastet O, Tauzin A, Brassard N, Beaudoin-Bussières G, Vézina D, Gong SY, Benlarbi M, Gasser R, Laumaea A, Bourassa C, et al. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen. Biorxiv : the Preprint Server For Biology. PMID 34981046 DOI: 10.1101/2021.12.18.473317  0.532
2021 Tauzin A, Gong SY, Beaudoin-Bussières G, Vézina D, Gasser R, Nault L, Marchitto L, Benlarbi M, Chatterjee D, Nayrac M, Laumaea A, Prévost J, Boutin M, Sannier G, Nicolas A, et al. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses. Cell Host & Microbe. PMID 34953513 DOI: 10.1016/j.chom.2021.12.004  0.445
2021 Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, Beaudoin-Bussières G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prévost J, Laumaea A, Niessl J, Nayrac M, et al. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Science Advances. 7: eabj5629. PMID 34826237 DOI: 10.1126/sciadv.abj5629  0.361
2021 Sannier G, Dubé M, Dufour C, Richard C, Brassard N, Delgado GG, Pagliuzza A, Baxter AE, Niessl J, Brunet-Ratnasingham E, Charlebois R, Routy B, Routy JP, Fromentin R, Chomont N, et al. Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity. Cell Reports. 36: 109643. PMID 34469719 DOI: 10.1016/j.celrep.2021.109643  0.355
2020 Niessl J, Baxter AE, Morou A, Brunet-Ratnasingham E, Sannier G, Gendron-Lepage G, Richard J, Delgado GG, Brassard N, Turcotte I, Fromentin R, Bernard NF, Chomont N, Routy JP, Dubé M, et al. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy. Ebiomedicine. 54: 102727. PMID 32268275 DOI: 10.1016/J.Ebiom.2020.102727  0.613
2020 Sannier G, Dubé M, Kaufmann DE. Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity. Frontiers in Microbiology. 11: 297. PMID 32194526 DOI: 10.3389/Fmicb.2020.00297  0.427
2020 Niessl J, Baxter AE, Mendoza P, Jankovic M, Cohen YZ, Butler AL, Lu CL, Dubé M, Shimeliovich I, Gruell H, Klein F, Caskey M, Nussenzweig MC, Kaufmann DE. Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. Nature Medicine. PMID 32015556 DOI: 10.1038/S41591-019-0747-1  0.546
2020 Prévost J, Edgar CR, Richard J, Trothen SM, Jacob RA, Mumby MJ, Pickering S, Dubé M, Kaufmann DE, Kirchhoff F, Neil SJD, Finzi A, Dikeakos JD. HIV-1 Vpu downregulates Tim-3 from the surface of infected CD4 T cells. Journal of Virology. PMID 31941771 DOI: 10.1128/Jvi.01999-19  0.619
2019 Morou A, Brunet-Ratnasingham E, Dubé M, Charlebois R, Mercier E, Darko S, Brassard N, Nganou-Makamdop K, Arumugam S, Gendron-Lepage G, Yang L, Niessl J, Baxter AE, Billingsley JM, Rajakumar PA, et al. Altered differentiation is central to HIV-specific CD4 T cell dysfunction in progressive disease. Nature Immunology. PMID 31308541 DOI: 10.1038/S41590-019-0418-X  0.513
2019 Prévost J, Pickering S, Mumby MJ, Medjahed H, Gendron-Lepage G, Delgado GG, Dirk BS, Dikeakos JD, Stürzel CM, Sauter D, Kirchhoff F, Bibollet-Ruche F, Hahn BH, Dubé M, Kaufmann DE, et al. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses. Mbio. 10. PMID 31213558 DOI: 10.1128/Mbio.01113-19  0.588
2019 Brunet-Ratnasingham E, Dubé M, Kaufmann DE. Targeting Mitochondria to Revive Dysfunctional Regulatory T Cells. Trends in Molecular Medicine. 25: 1-3. PMID 30473188 DOI: 10.1016/J.Molmed.2018.11.001  0.471
2018 Porichis F, Hart MG, Massa A, Everett HL, Morou A, Richard J, Brassard N, Veillette M, Hassan M, Ly NL, Routy JP, Freeman GJ, Dubé M, Finzi A, Kaufmann DE. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 29934472 DOI: 10.4049/Jimmunol.1701551  0.622
2013 Dube MW. HIV+ feminisms, postcoloniality and the global AIDS crisis Another World Is Possible: Spiritualities and Religions of Global Darker Peoples. 145-159.  0.307
2012 Dube MW. Mainstreaming HIV/AIDS in African religious and theological studies African Traditions in the Study of Religion in Africa: Emerging Trends, Indigenous Spirituality and the Interface With Other World Religions. 77-92.  0.308
Show low-probability matches.